Search
SOLACI Congress
HomeValvular Aortic valveVálvula Aórtica

Válvula Aórtica

View Category
Structural heart disease

One-Year Mortality Trends Following TAVR: STS/ACC TVT Registry Outcomes

Transcatheter aortic valve replacement (TAVR) has quickly consolidated as a safe and effective treatment option for patients...
Dr. Andrés Rodríguez -
Learn More
Structural heart disease

Is Transcarotid Access a Safe Option in TAVI?

Transcatheter aortic valve implantation (TAVI) should preferably be conducted via transfemoral access, according to European guideline (in...
Dr. Carlos Fava -
Learn More
Structural heart disease

5th Generation Balloon Expandable Valve in a Real World US Population: One-Year Outcomes

Transcatheter aortic valve replacement (TAVR) has consolidated as treatment for severe symptomatic aortic stenosis, even in low...
Dr. Andrés Rodríguez -
Learn More
Structural heart disease

ACURATE Neo2 Underexpansion: Prevalence and Clinical Implications

While transcatheter aortic valve replacement (TAVR) provides durable clinical benefits across a wide range of patients, technical...
Dr. Omar Tupayachi -
Learn More
Structural heart disease

Measuring Post-TAVI Gradients and Their Implications: Are Invasive and Echocardiographic Assessments Comparable?

Transcatheter aortic valve implantation (TAVI) is considered the treatment of choice for a significant proportion of patients...
Dr. Omar Tupayachi -
Learn More
Structural heart disease

Percutaneous Tricuspid Valve Replacement with Lux-Valve

Tricuspid regurgitation (TR) is a condition associated with poor quality of life, frequent hospitalizations due to heart...
Dr. Carlos Fava -
Learn More
Structural heart disease

TAVR in Small Annuli: What Valve Should We Use?

One of the major challenges of severe aortic stenosis are patients with small aortic annuli, defined as...
Dr. Carlos Fava -
Learn More
Structural heart disease

ACC 2025 | TAVI in Low-Risk Patients: 5-Year Outcomes of EVOLUTE LOW RISK

Transcatheter aortic valve implantation (TAVI) is a valid alternative to surgery in low-risk patients with severe aortic...
Dr. Carlos Fava -
Learn More

SOLACI is the reference organization for Latin American cardiovascular interventionism.

Last News

Cangrelor in Acute and Chronic Coronary Syndromes: The POMPEII Registry

Dr. Omar Tupayachi - 0
Platelet inhibition during and after coronary angioplasty is essential to prevent peri- and post-procedural ischemic events. To that end, cangrelor, an intravenous P2Y12 receptor...

One-Year Mortality Trends Following TAVR: STS/ACC TVT Registry Outcomes

Dr. Andrés Rodríguez - 0
Transcatheter aortic valve replacement (TAVR) has quickly consolidated as a safe and effective treatment option for patients with severe symptomatic aortic stenosis. At present,...

Hyper-Adducted Right Radial Access vs. Left Radial Access: Aiming for Lower Daily Radiation Exposure

Dr. Omar Tupayachi - 0
Interventional cardiologists face one of the most extreme occupational hazards: ionizing radiation. The right radial access (RRA) has been established as the preferred alternative...

Institutional News

SOLACI Symposium at the EuroPCR 2025 Congress

solaci - 0
The Latin American Society of Interventional Cardiology (SOLACI) makes a strong appearance once again at one of the most important congresses in the field...

See the best images from the Uruguay 2025 Sessions

solaci - 0
Enjoy the best moments of the Uruguay 2025 Conference, held at the Radisson Hotel in Montevideo (Uruguay) on May 7, 8, and 9, 2025. <!--...

How to apply for the SOLACI Research 2025 Grant? Step-by-step explanation video

solaci - 0
You can now rewatch the virtual event we held on April 9th, where we thoroughly reviewed the steps to apply for the SOLACI Research...

Access

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Terms of Use -Privacy Policy